Cargando…

Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasia

BACKGROUND: To assess the ejaculatory disorder caused by silodosin in the prostatic hyperplasia patients who carry out sexual actions (sexual intercourse, masturbation). METHOD: The subjects of this study were 91 patients who had been clinically diagnosed to have LUTS/BPH at this hospital, who were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakata, Koichi, Morita, Tatsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507909/ https://www.ncbi.nlm.nih.gov/pubmed/23082785 http://dx.doi.org/10.1186/1471-2490-12-29

Ejemplares similares

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
por: Yoshida, Masaki, et al.
Publicado: (2011)

Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability
por: Cho, Hee Ju, et al.
Publicado: (2014)

Evaluation of silodosin in comparison to tamsulosin in benign prostatic hyperplasia: A randomized controlled trial
por: Pande, Satabdi, et al.
Publicado: (2014)

The Effectiveness of Silodosin for Nocturnal Polyuria in Elderly Men With Benign Prostatic Hyperplasia: A Multicenter Study
por: Kim, Young Won, et al.
Publicado: (2015)

Effect of Silodosin, an Alpha1A-Adrenoceptor Antagonist, on Ventral Prostatic Hyperplasia in the Spontaneously Hypertensive Rat
por: Shimizu, Shogo, et al.
Publicado: (2015)

A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia
por: Manjunatha, R., et al.
Publicado: (2016)

Patient-reported ejaculatory function and satisfaction in men with lower urinary tract symptoms/benign prostatic hyperplasia
por: Cho, Min Chul, et al.
Publicado: (2018)

The office management of ejaculatory disorders
por: Jiann, Bang-Ping
Publicado: (2016)

Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Poor Response to Existing Alpha-1 Blockers: The SPLASH Study
por: Takahashi, Hiroshi, et al.
Publicado: (2019)

Effect of silodosin on specific urinary symptoms associated with benign prostatic hyperplasia: analysis of international prostate symptom scores in 2 phase III clinical studies
por: Gittelman, Marc C, et al.
Publicado: (2010)

Evolving Role of Silodosin for the Treatment of Urological Disorders – A Narrative Review
por: Jindan, Luo, et al.
Publicado: (2022)

The Persistence of Silodosin Monotherapy and the Reasons for Withdrawal from Treatment of Previously Untreated Japanese Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
por: Tanaka, Yoshinori, et al.
Publicado: (2017)

Ejaculatory dysfunction
por: McMahon, Chris G.
Publicado: (2016)

Evaluation of Silodosin and Pelvic Floor Muscle Training in Men with Benign Prostatic Hyperplasia and Overactive Bladder (Silodosing) Study Protocol (Spirit Compliant)
por: Hagovska, Magdalena, et al.
Publicado: (2021)

Study on the effect of completely preserving the ejaculatory duct during prostatectomy on reducing postoperative retrograde ejaculation in benign prostatic hyperplasia patients
por: Zhang, Lufeng, et al.
Publicado: (2022)

Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study
por: Hagiwara, Kazuhisa, et al.
Publicado: (2016)

Prospective comparison of tadalafil 5 mg alone, silodosin 8 mg alone, and the combination of both in treatment of lower urinary tract symptoms related to benign prostatic hyperplasia
por: AbdelRazek, Mostafa, et al.
Publicado: (2022)

Evaluation of static and dynamic Pupillometry changes in men using Silodosin for benign prostatic hypertrophy
por: Karaca, Umut, et al.
Publicado: (2021)

Successful treatment of ejaculation pain with silodosin in patient with Zinner syndrome: a case report
por: Uetani, Masato, et al.
Publicado: (2023)

Ejaculatory disorders after prostatic artery embolization: a reassessment of two prospective clinical trials
por: Müllhaupt, Gautier, et al.
Publicado: (2019)

Focus on Silodosin: Pros and Cons of Uroselectivity
por: Califano, Gianluigi, et al.
Publicado: (2020)

A state-of-art review on the preservation of sexual function among various minimally invasive surgical treatments for benign prostatic hyperplasia: Impact on erectile and ejaculatory domains
por: Ng, Brian Hung Shin, et al.
Publicado: (2021)

AB028. The diagnosis and treatment of ejaculatory dysfunction
por: Wang, Jingqi, et al.
Publicado: (2018)

Contemporary management of ejaculatory dysfunction
por: Gray, Marisa, et al.
Publicado: (2018)

Comparison of tamsulosin and silodosin in the management of acute urinary retention secondary to benign prostatic hyperplasia in patients planned for trial without catheter. A prospective randomized study
por: Patil, Siddangouda B., et al.
Publicado: (2017)

Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone
por: Boeri, Luca, et al.
Publicado: (2017)

Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?
por: Kaplan, Steven A, et al.
Publicado: (2011)

Ejaculatory and Orgasmic Dysfunction Following Prostate Cancer Therapy: Clinical Management
por: Green, Travis P., et al.
Publicado: (2019)

Traditional, Complementary and Alternative Medicines in the Treatment of Ejaculatory Disorders: A Systematic Review
por: Leisegang, Kristian, et al.
Publicado: (2023)

Clinical review of ejaculatory dysfunction
por: Otani, Toshikazu
Publicado: (2019)

A Suspected Case of Silodosin-Induced Erythroderma
por: Liu, Annie, et al.
Publicado: (2015)

Silodosin-associated intraoperative floppy iris syndrome
por: Chatterjee, Samrat, et al.
Publicado: (2017)

Comparing tamsulosin, silodosin versus silodosin plus tadalafil as medical expulsive therapy for lower ureteric stones: A randomised trial
por: Rahman, Md Jawaid, et al.
Publicado: (2017)

New Concepts in the Investigation and Treatment of Prostatic Hyperplasia
por: McLoughlin, J.
Publicado: (1992)

Ejaculatory physiology and pathophysiology: assessment and treatment in male infertility
por: Revenig, Louis, et al.
Publicado: (2014)

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms
por: DeLay, Kenneth Jackson, et al.
Publicado: (2016)

Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle
por: Hennenberg, Martin, et al.
Publicado: (2012)

Transurethral resection of ejaculatory duct combined with seminal vesiculoscopy for management of persistent or recurrent hemospermia in men with ejaculatory duct obstruction
por: Ren, Zheng-Ju, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ac7qdsajd4cp6q5odfea1d9hdo